NanoEcho’s report for the third quarter is now published — and for the first time, commercial revenues are being reported!
“The quarter demonstrates steady and focused progress. During the period, we issued our first invoice to a customer while continuing to make clinical adaptations to the system ahead of the next study — a combination that is clearly driving NanoEcho forward towards our goal of turning our technology into real patient benefit and long-term commercial success,” comments CEO Linda Persson.
Watch CEO Linda Persson summarise the quarter below!